Trial Summary
What is the purpose of this trial?This pilot study aims to assess the feasibility of carrying out a full-scale pragmatic, cluster-randomized controlled trial which will investigate whether discharge summary writing assisted by a large language model (LLM), called CURE (Checker for Unvalidated Response Errors), improves care delivery without adversely impacting patient outcomes.
Eligibility Criteria
This trial is for hospitalized patients with aphasia, a condition that affects communication. The study will explore if using a large language model to assist in writing discharge summaries can improve care without negatively affecting patient outcomes.Inclusion Criteria
Adult patients admitted to one of three participating cardiology services at Mayo Clinic in Rochester, MN
Clinicians who provide care to randomized patients included in this pilot
Exclusion Criteria
Patients admitted to a hospital service where CURE is not implemented
Clinicians who do not provide care to randomized patients included in this pilot
I am under 18 years old.
Participant Groups
The intervention being tested is CURE, a large language model designed to help write discharge summaries for patients. The trial will determine its effectiveness and safety in clinical settings through a pragmatic, cluster-randomized controlled design.
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Clinicians who care for patients randomized to intervention will have access to CURE to assist with discharge summary writing.
Group II: ControlActive Control1 Intervention
Clinicians who care for patients randomized to control will continue with standard practice for discharge summary writing.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Mayo ClinicRochester, MN
Loading ...
Who Is Running the Clinical Trial?
Mayo ClinicLead Sponsor